Pyxis Oncology, Inc. · NASDAQ:PYXS
Dupont Jakob sold 35,000 Pyxis Oncology, Inc. shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Dupont Jakob (Director) sold 35,000 Pyxis Oncology, Inc. shares at US$3.06 for US$107K under a trading plan, leaving 38,741 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 35,000 shares
- Price
- US$3.06
- Value
- US$107K
- Holding after
- 38,741 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Option exercise | 35,000 | US$1.60 | 73,741 | Direct |
| Jun 30, 2026 | Common Stock | Sale | 35,000 | US$3.06 | 38,741 | Direct |
Source
Related
- Pyxis Oncology, Inc.
- Dupont Jakob
- Pyxis Oncology, Inc. shareholders
- Schedule 13G/A · GordonMD Global Investments LP · Oct 9, 2026
- Schedule 13G · Coastlands Capital LP · Oct 5, 2026
- Form 4 · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G/A · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Jul 10, 2026